拉坦前列腺素内酯二醇结构式
|
常用名 | 拉坦前列腺素内酯二醇 | 英文名 | Latanoprost lactone diol |
|---|---|---|---|---|
| CAS号 | 145667-75-0 | 分子量 | 304.381 | |
| 密度 | 1.2±0.1 g/cm3 | 沸点 | 523.0±35.0 °C at 760 mmHg | |
| 分子式 | C18H24O4 | 熔点 | 69-71ºC | |
| MSDS | N/A | 闪点 | 190.3±19.4 °C |
拉坦前列腺素内酯二醇用途Latanoprost lactone diol 是合成 Latanoprost 的中间体。Latanoprost 是前列腺素 F2α 类似物,是一种前列腺素受体 (FP prostanoid receptor) 激动剂,可降低眼内压 (IOP)。 |
| 中文名 | 拉坦前列腺素内酯二醇 |
|---|---|
| 英文名 | (3aR,4R,5R,6aS)-5-hydroxy-4-[(3R)-3-hydroxy-5-phenylpentyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-one |
| 中文别名 | 2H-环戊并[B]呋喃-2-酮,六氢-5-羟基-4-[(3R)-3-羟基-5-苯基戊烷基]-,(3AR,4R,5R,6AS)-(...) | (3AR,4R,5R,6AS)-六氢-5-羟基-4-[(3R)-3-羟基-5-苯基戊基]-2H-环戊并[B]呋喃-2-酮 | 拉坦前列素内酯二醇 |
| 英文别名 | 更多 |
| 描述 | Latanoprost lactone diol 是合成 Latanoprost 的中间体。Latanoprost 是前列腺素 F2α 类似物,是一种前列腺素受体 (FP prostanoid receptor) 激动剂,可降低眼内压 (IOP)。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 523.0±35.0 °C at 760 mmHg |
| 熔点 | 69-71ºC |
| 分子式 | C18H24O4 |
| 分子量 | 304.381 |
| 闪点 | 190.3±19.4 °C |
| 精确质量 | 304.167450 |
| PSA | 66.76000 |
| LogP | 0.60 |
| InChIKey | CQVHXVLSHMRWEC-UTSKFRMZSA-N |
| SMILES | O=C1CC2C(CC(O)C2CCC(O)CCc2ccccc2)O1 |
| 蒸汽压 | 0.0±1.4 mmHg at 25°C |
| 折射率 | 1.568 |
|
~79%
拉坦前列腺素内酯二醇 145667-75-0 |
| 文献:Chirogate International Inc. Patent: EP1810967 A1, 2007 ; Location in patent: Page/Page column 20-21 ; |
|
~85%
拉坦前列腺素内酯二醇 145667-75-0 |
| 文献:Resul, Bahram; Stjernschantz, Johan; No, Kiyo; Liljebris, Charlotta; Selen, Goeran; et al. Journal of Medicinal Chemistry, 1993 , vol. 36, # 2 p. 243 - 248 |
|
~%
拉坦前列腺素内酯二醇 145667-75-0 |
| 文献:EP1886992 A1, ; Page/Page column 9 ; |
|
~%
拉坦前列腺素内酯二醇 145667-75-0 |
| 文献:Journal of Medicinal Chemistry, , vol. 36, # 2 p. 243 - 248 |
|
~%
拉坦前列腺素内酯二醇 145667-75-0 |
| 文献:Journal of Medicinal Chemistry, , vol. 36, # 2 p. 243 - 248 |
|
~%
拉坦前列腺素内酯二醇 145667-75-0 |
| 文献:Journal of Medicinal Chemistry, , vol. 36, # 2 p. 243 - 248 |
|
~%
拉坦前列腺素内酯二醇 145667-75-0 |
| 文献:Journal of Medicinal Chemistry, , vol. 36, # 2 p. 243 - 248 |
|
~%
拉坦前列腺素内酯二醇 145667-75-0 |
| 文献:Journal of Medicinal Chemistry, , vol. 36, # 2 p. 243 - 248 |
|
实验名称:Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:HCMV UL50
External Id:HMS1262
|
|
实验名称:A screen for small molecules that modulate mitochondrial supercomplex formation
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:N/A
External Id:HMS1482
|
|
实验名称:Cell-based high throughput primary assay to identify activators of GPR151
来源:The Scripps Research Institute Molecular Screening Center
靶标:RecName: Full=G-protein coupled receptor 151; AltName: Full=G-protein coupled receptor PGR7; AltName: Full=GPCR-2037; AltName: Full=Galanin receptor 4; AltName: Full=Galanin-receptor-like protein; Short=GalRL
External Id:GPR151_PHUNTER_AG_LUMI_1536_1X%ACT
|
|
实验名称:AlphaScreen-based biochemical high throughput primary assay to identify inhibitors of...
来源:The Scripps Research Institute Molecular Screening Center
External Id:MITF_INH_Alpha_1536_1X%INH PRUN
|
|
实验名称:Stabilization of p53 in human papillomavirus-positive cells
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:Cellular tumor antigen p53
External Id:HMS1485
|
| (3aR,4R,5R,6aS)-5-Hydroxy-4-[(3R)-3-hydroxy-5-phenylpentyl]hexahydro-2H-cyclopenta[b]furan-2-one |
| LatanoprostLactoneDiol |